The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes

Congenital myasthenic syndromes (CMS) are genetic disorders characterised by impaired neuromuscular transmission. This review provides an overview on CMS and highlights recent advances in the field, including novel CMS causative genes and improved therapeutic strategies. CMS due to mutations in SLC5...

Полное описание

Библиографические подробности
Главные авторы:	Rodríguez Cruz, P, Palace, J, Beeson, D
Формат:	Journal article
Язык:	English
Опубликовано:	MDPI 2018

Схожие документы

Congenital myasthenic syndromes and the neuromuscular junction.
по: Cruz, P, и др.
Опубликовано: (2014)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
по: Beeson, D, и др.
Опубликовано: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
по: Beeson, D, и др.
Опубликовано: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
по: Beeson, D
Опубликовано: (2008)

The congenital myasthenic syndromes.
по: Palace, J, и др.
Опубликовано: (2008)

Congenital myasthenic syndromes.
по: Beeson, D, и др.
Опубликовано: (1997)

Congenital myasthenic syndromes: an update.
по: Finlayson, S, и др.
Опубликовано: (2013)

The role of Rapsyn in neuromuscular junction and congenital myasthenic syndrome
по: Xufeng Liao, и др.
Опубликовано: (2023-09-01)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
по: Cossins, J, и др.
Опубликовано: (2012)

Therapeutic strategies for congenital myasthenic syndromes
по: Lee, M, и др.
Опубликовано: (2018)

Congenital myasthenic syndromes: Epidemiology, clinical phenotyping and aids to diagnosis in the neuromuscular clinic
по: Healy, E, и др.
Опубликовано: (2014)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
по: Lashley, D, и др.
Опубликовано: (2009)

Inherited disorders of the neuromuscular junction: an update.
по: Rodríguez Cruz, P, и др.
Опубликовано: (2014)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
по: Man, S, и др.
Опубликовано: (2005)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
по: Lashley, D, и др.
Опубликовано: (2010)

Synaptic dysfunction in congenital myasthenic syndromes.
по: Beeson, D
Опубликовано: (2012)

Congenital myasthenic syndromes: recent advances
по: Beeson, D
Опубликовано: (2016)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
по: Burke, G, и др.
Опубликовано: (2006)

DOK7 congenital myasthenic syndrome.
по: Palace, J
Опубликовано: (2012)

Clinical and experimental observations in patients with congenital myasthenic syndromes.
по: Vincent, A, и др.
Опубликовано: (1993)

Clinical and experimental observations in patients with congenital myasthenic syndromes.
по: Vincent, A, и др.
Опубликовано: (1993)

Muscle magnetic resonance imaging in congenital myasthenic syndromes
по: Finlayson, S, и др.
Опубликовано: (2016)

Animal models of the neuromuscular junction, vitally informative for understanding function and the molecular mechanisms of congenital myasthenic syndromes
по: Webster, R
Опубликовано: (2018)

Effect of β2-adrenergic receptor agonists on neurotransmission and neuromuscular junction structure in congenital myasthenic syndromes
по: Vanhaesebrouck, A
Опубликовано: (2018)

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
по: Finlayson, S, и др.
Опубликовано: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
по: Finlayson, S, и др.
Опубликовано: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
по: Finlayson, S, и др.
Опубликовано: (2013)

Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
по: Kinali, M, и др.
Опубликовано: (2008)

Congenital myasthenic syndrome caused by mutations in DPAGT.
по: Klein, A, и др.
Опубликовано: (2015)

THE CLINICAL PHENOTYPIC SPECTRUM OF GFPT1 ASSOCIATED CONGENITAL MYASTHENIC SYNDROME
по: Chaouch, A, и др.
Опубликовано: (2012)

Congenital myasthenic syndromes: Report of 7 Chile
по: Kleinsteuber, K, и др.
Опубликовано: (2003)

AN UNUSUAL CASE OF CONGENITAL MYASTHENIC SYNDROME: THE MECHANISM FOR TREATMENT RESPONSE
по: Spillane, J, и др.
Опубликовано: (2012)

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
по: Belaya, K, и др.
Опубликовано: (2012)

Congenital Myasthenic Syndromes
по: J Gordon Millichap
Опубликовано: (1994-01-01)

Therapy of myasthenic syndrome
по: Palace, J
Опубликовано: (2012)

Congenital myasthenic syndromes
по: Josef Finsterer
Опубликовано: (2019-02-01)

Congenital myasthenic syndrome due to mutations in MUSK suggests that the level of MuSK phosphorylation is crucial for governing synaptic structure
по: Rodríguez Cruz, PM, и др.
Опубликовано: (2019)

Congenital Myasthenic Syndrome
по: WANG Wenqing, и др.
Опубликовано: (2022-04-01)

New diagnosis in Chilean population: congenital myasthenic syndromes
по: Kleinsteuber, K, и др.
Опубликовано: (2005)

Dok-7/MuSK signaling and a congenital myasthenic syndrome.
по: Yamanashi, Y, и др.
Опубликовано: (2008)